Crystal Egg Bio

company

About

Crystal Egg Bio is a biopharmaceutical research company engaged in the development of membrane protein drugs for treating major diseases.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Crystal Egg is a biopharmaceutical company dedicated to the independent research and development of first in class innovative new drugs for major diseases such as depression, chronic kidney disease, pain and rare diseases, as well as providing customers with high-quality products and R&D services in membrane protein-related fields. enterprise. The company has built membrane protein expression and purification platforms, structural biology platforms, pharmacology platforms and nanobody screening platforms, and has rich R&D pipelines in the fields of ion channels and GPCRs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Crystal Egg Bio has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 7, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2022 Seed 1 Longmen Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Crystal Egg Bio is funded by 1 investors. Longmen Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Longmen Capital Yes Seed